Oculis Holding AG completed a substantial equity financing on October 29, 2025, comprising an Underwritten Offering and a Registered Direct Offering, raising approximately \(110.0 million in gross proceeds from the sale of 5,432,098 ordinary shares at \)20.25 per share. Underwriters (J.P. Morgan, Leerink Partners, Pareto Securities) hold a 30-day option to purchase up to 703,703 additional shares, which could raise total gross proceeds to \(124.2 million. The company expects these net proceeds, combined with existing cash, to fund operations until late 2028. The Registered Direct portion (\)15.0 m
...